๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Preliminary results of a pilot-trial with trastuzumab + weekly epidoxorubicin/docetaxel in the neoadjuvant treatment of primary, operable breast cancer

โœ Scribed by G.G. Steger; C. Wenzel; R. Bartsch; M. Rudas; M.F. Gnant; C.C. Zielinski; R. Jakesz

Book ID
114315652
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
413 KB
Volume
12
Category
Article
ISSN
0960-9776

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

CMF + radiotherapy in the primary treatm
CMF + radiotherapy in the primary treatment of operable breast cancer: Preliminary results of a phase II pilot study
โœ Bellantone, Rocco; Lombardi, Celestino Pio; Cefaro, Giampiero Ausili; Nardone, L ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 47 KB ๐Ÿ‘ 2 views

Background and Objectives: Chemotherapy and radiotherapy have been investigated in several studies about their role in primary (neoadjuvant) treatment before surgery in breast cancer. We proposed a pilot study to evaluate a primary scheme of alternate radio-chemotherapy in the treatment of operable

Docetaxel plus epidoxorubicin as neoadju
Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast : A single-center, Phase II study
โœ Andrea de Matteis; Francesco Nuzzo; Giuseppe D'Aiuto; Vincenzo Labonia; Gabriell ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 76 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND The objective of this study was to test the activity and toxicity of epirubicin plus docetaxel as primary chemotherapy for women with large, operable (T2; > 3 cm) or locally advanced (Stage III) breast carcinoma, including patients with inflammatory breast carcinoma. ##